Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of higher doses of modified release huperzine formulations

Use of higher doses of modified release huperzine formulations

US Patent 11351120 · Granted Jun 7, 2022

Estimated economic value: $12,727,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Use of higher doses of modified release huperzine formulations2025
Use of higher doses of modified release huperzine formulations2025
Modified release pharmaceutical compositions of huperzine and methods of using t2025
Modified release pharmaceutical compositions of huperzine and methods of using t2025
Halogenated derivatives of morphinans and uses thereof2022
Parenteral carbamazepine formulation2017
Parenteral carbamazepine formulation2017
Use of tiagabine for treatment of diabetic neuropathy and migraine2005